| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0053 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.005 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |